Stock listing

Transgene Sa

Selected listing: TGNA · SWB · EUR · DE

Transgene Sa (Stuttgart:TGNA), Health Technology. Latest release Oct 5, 2026: Transgene Will Present a Poster on Preclinical Data from a Novel Oncolytic Virus…

TGNA:SWBEURDEUpdated October 3, 2026

Ticker: Stuttgart:TGNA
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: Stuttgart
Currency: EUR

About Transgene Sa

The company focuses on developing innovative immunotherapies for the treatment of cancer and infectious diseases. Transgene is committed to advancing its proprietary technologies to improve patient outcomes.

Latest news from Transgene Sa

Transgene Will Present a Poster on Preclinical Data from a Novel Oncolytic Virus at SITC 2026

October 5, 2026

Transgene to Participate in Investor Access

October 1, 2026

Transgene participera à l’Investor Access

September 30, 2026

Transgene Extends its myvac® Platform, Further Establishing its Position as a Key Player in the Rapidly Emerging Individualized Cancer Immunotherapy Field

September 24, 2026

Mise à disposition du Rapport Financier Semestriel au 30 juin 2026

September 23, 2026

All Transgene Sa news →

Events

Replays

Transgene S.A. (0OCQ) Q4 2025 Earnings Call
Tue, Mar 24, 2026 · 01:00 PM ET
Watch
Transgene S.A. (0OCQ) Q2 2025 Earnings Call
Tue, Sep 16, 2025 · 12:00 PM ET
Watch

Research Transgene Sa

Transgene Sa company profile

View the public company page for Transgene Sa on 6ix.

Transgene Sa news

Read company news and market updates connected to Transgene Sa.

Transgene Sa investor events

Find investor webinars, events, and replay context for Transgene Sa.